Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/2000
11/09/2000WO2000066736A1 Growth factor homolog zvegf4
11/09/2000WO2000066732A2 Laminin 8 and methods for its use
11/09/2000WO2000066630A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS
11/09/2000WO2000066618A1 Integrin receptor antagonists
11/09/2000WO2000066611A1 Steroid derivatives
11/09/2000WO2000066577A2 Brigded cycloalkanes as thromboxane ligands without blood clotting effects
11/09/2000WO2000066557A1 New compounds
11/09/2000WO2000066555A1 Thio-oxindole derivatives
11/09/2000WO2000066550A1 New compounds
11/09/2000WO2000066545A1 6-[[(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof
11/09/2000WO2000066148A1 Novel proteins
11/09/2000WO2000066130A1 Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate
11/09/2000WO2000066128A1 Method of enhancing insulin action
11/09/2000WO2000066112A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics
11/09/2000WO2000066111A1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/09/2000WO2000066094A2 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000WO2000039087A3 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
11/09/2000WO2000032584A3 Nonsteroidal antiinflammatories
11/09/2000WO2000030668A3 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
11/09/2000WO2000010968A3 Novel aryl sulphonamide amino acid esters and analogues
11/09/2000CA2372948A1 Method of enhancing insulin action
11/09/2000CA2372923A1 Dna encoding snorf36a and snorf36b receptors
11/09/2000CA2372772A1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/09/2000CA2372493A1 Steroid derivatives
11/09/2000CA2371633A1 Thio-oxindole derivatives
11/09/2000CA2371604A1 Integrin receptor antagonists
11/09/2000CA2371284A1 6-¬¬(aryl and heteroaryl)oxy| methyl|naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof
11/09/2000CA2371231A1 Pharmaceutical composition in unit form containing acetylsalicylic acid and clopidogrel hydrogenosulphate
11/09/2000CA2371215A1 New compounds
11/09/2000CA2369526A1 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000CA2338799A1 Protein c derivatives
11/08/2000EP1050534A1 2,3-methano-amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
11/08/2000EP1049776A1 Phagocytosis genes and uses thereof
11/08/2000EP1049770A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049721A1 Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same
11/08/2000EP1049714A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049706A1 New pentasaccharides, their methods of production and pharmaceutical compositions containing same
11/08/2000EP1049693A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS $g(a) v?$g(b) 3? ANTAGONISTS
11/08/2000EP1049689A1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
11/08/2000EP1049673A1 Heterocyclic amidines as callicrein protease inhibitors
11/08/2000EP1049487A2 Method for treating acute intermittent porphyria (aip) and other porphyric diseases
11/08/2000EP1049485A1 Enhancement of hematopoietic cells
11/08/2000EP1049467A1 Celecoxib compositions
11/08/2000EP1030567A4 System, method and composition for dialysis and shock treatment
11/08/2000EP0655089B1 Effects of actin filaments on fibrin clot structure and lysis
11/08/2000CN1272841A Novel lactam metalloprotease inhibitors
11/08/2000CN1272784A Medicinal compositions for application to mucosa
11/08/2000CN1058294C Method for preparation of compound named 'Leustroducsins'
11/08/2000CN1058184C Gynaecologist's hemostatic
11/07/2000US6143770 Mixtures of tocotrienol and nicotinic acid
11/07/2000US6143741 Treating or preventing illnesses resulting from damaged endothelial cells such as atherosclerosis, thrombosis, restenosis, vessel spasm by administering hydroxylamine derivative
11/07/2000US6143719 Bradykinin analogs as selective thrombin inhibitors
11/07/2000CA2118102C New derivatives of 1,2,3,4-tetrahydronaphthalene, preparation process thereof and pharmaceutical compositions containing the same
11/02/2000WO2000066152A1 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor
11/02/2000WO2000065054A2 Human membrane-associated proteins
11/02/2000WO2000065028A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
11/02/2000WO2000064894A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
11/02/2000WO2000064880A1 Selective npy (y5) antagonists
11/02/2000WO2000064485A2 Specifically targeted catalytic antagonists and uses thereof
11/02/2000WO2000064470A1 A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
11/02/2000WO2000064451A1 Use of tagatose to enhance key blood factors
11/02/2000WO2000064449A1 Thrombin inhibitors
11/02/2000WO2000064442A1 Novel anticoagulant injectable composition
11/02/2000WO2000064436A1 Methods of delivery of cetyl myristoleate
11/02/2000WO2000064430A1 Apoptosis inhibitors
11/02/2000WO2000064420A2 Compositions and methods for treating amyloidosis using sulphonate derivatives
11/02/2000WO2000039136A3 Human brainiac-5
11/02/2000WO2000030622A3 Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases
11/02/2000WO2000029029A9 Compositions and methods for producing vascular occlusion
11/02/2000EP1048725A1 Process for production of mammalian cell lines, produced cell lines and their uses
11/02/2000EP1047772A1 Secreted proteins and polynucleotides encoding them
11/02/2000EP1047713A1 Secreted proteins and polynucleotides encoding them
11/02/2000EP1047699A1 Platelet adp receptor inhibitors
11/02/2000EP1047452A1 Conjugates comprising two active agents
11/02/2000EP1047441A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
11/02/2000CA2371274A1 Selective npy (y5) antagonists
11/02/2000CA2371241A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor
11/02/2000CA2371217A1 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor
11/02/2000CA2371064A1 Methods of delivery of cetyl myristoleate
11/02/2000CA2371008A1 A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
11/02/2000CA2370576A1 Novel anticoagulant injectable composition
11/02/2000CA2370264A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
11/02/2000CA2370195A1 Human membrane-associated proteins
11/02/2000CA2369109A1 Thrombin inhibitors
11/02/2000CA2368213A1 Specifically targeted catalytic antagonists and uses thereof
11/01/2000CN1272111A Tricyclic vasopressin agonists
11/01/2000CN1272107A Benzamidine derivatives as factor Xa inhibitors
11/01/2000CN1272061A Universally applicable blood plasma
11/01/2000CN1271577A Medicine preparation and its use and the use of high grade primary alcohol mixture
11/01/2000CN1058019C 环状氨基酸衍生物 Cyclic amino acid derivatives
11/01/2000CN1058013C Process for preparation of novel mercaptoacetylamide derivatives
11/01/2000CN1058008C Phenyl heterocycles as cyclooxygenase-2 inhibitors
11/01/2000CN1057933C Process for preparation of Chinese medicine for cerebral thrombus
11/01/2000CN1057924C Drug preparation for curing viral and many kinds of myocarditis, low fever and hypokalemia
10/2000
10/31/2000US6140504 Substituted intermediate compounds for the preparation of n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
10/31/2000US6140466 Comprises at least three zinc finger domains that bind to target cellular nucleotide sequence and modulate its transcription; genome-specific transcriptional switches in gene therapy; transgenic plants and animals
10/31/2000US6140363 Administering rosmarinic acid, its derivative or prunella vulgaris extract for suppressing immune response for treatment, prevention, or diagnosis of rejection of transplanted organ or tissue, chronic rejection
10/31/2000US6140327 Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor
10/31/2000US6139882 Drugs, foods, beverages, animal feed
10/31/2000US6139856 Composition useful for providing one-step surgical preparation and drape
1 ... 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 ... 671